Timing Nuclear Entry: How A Human Virus Exploits The Cell Cycle

Jenn Hoskins
31st May, 2025

Timing Nuclear Entry: How A Human Virus Exploits The Cell Cycle

Disrupting nuclear envelope reformation via CHMP7 knockdown (a, b) resulted in increased nuclear permeability (c, d) and visible membrane gaps (e), which significantly enhanced Merkel cell polyomavirus infection (f), confirming that the virus exploits envelope breakdown to bypass the nuclear barrier.

Image adapted from: Wang et al. / CC BY (Source)

Key Findings

  • At the University of Michigan and Fred Hutch, researchers found that Merkel cell polyomavirus uses cell division to access the nucleus—a critical step in its cancer-causing process
  • The virus’s VP1 protein exploits the temporary opening of the nuclear envelope during mitosis, bypassing the typical entry route through nuclear pores
  • Enhancing nuclear envelope permeability further boosted infection, emphasizing that the timing of cell division is key to the virus’s successful entry
[1] Researchers at the University of Michigan and Fred Hutchinson Cancer Center have recently uncovered an unusual strategy employed by Merkel cell polyomavirus (MCPyV) to invade the nuclei of host cells, a crucial step for viral replication and its role in cancer formation. MCPyV is the only polyomavirus definitively linked to Merkel cell carcinoma, a rare and aggressive skin cancer. Understanding how this virus enters the nucleus has been a longstanding challenge, given its unconventional approach compared to similar viruses. The study addresses one of the key issues in viral oncology: how does MCPyV deliver its genetic material into the host nucleus when many viruses rely on the nuclear pore complex (NPC) for entry? In contrast, this research shows that MCPyV bypasses the NPC entirely. Instead, the virus exploits a natural process in the host cell cycle—the breakdown of the nuclear envelope that occurs during mitosis—to gain access to the nucleus. The researchers found that the VP1 major capsid protein of MCPyV is sufficient to mediate this entry, highlighting a novel infection strategy that differs from other polyomaviruses. Previous work on human polyomaviruses, including studies of their molecular biology and pathogenicity, has set the stage for these findings. For example, earlier research described an increased discovery rate of human polyomaviruses and highlighted MCPyV’s unique traits, such as its presence in various tissues and its association with Merkel cell carcinoma[2]. These earlier investigations also noted that while MCPyV shares common features with other polyomaviruses, it has evolved distinctive genetic and mechanistic properties. This new study builds on those foundations and provides a clearer picture of its entry mechanism. Methodologically, the research team utilized synchronized cell cultures to observe the behavior of MCPyV during different stages of the cell cycle. By carefully tracking the virus as cells progressed through mitosis, the scientists demonstrated that the breakdown of the nuclear envelope—a temporary disassembly of the barrier separating the nucleus from the cytoplasm—creates an opportunity for MCPyV to enter. Using imaging techniques and molecular markers, they confirmed that viral DNA enters the nucleus during the period when the nuclear envelope is disrupted. This observation supports the idea that MCPyV does not require the active transport machinery of the NPC, which is used by many other DNA viruses, including the well-studied simian virus SV40[3]. The researchers also focused on the molecular components of the virus, particularly the VP1 major capsid protein. VP1 is responsible for forming the outer shell of the virus particle and mediating initial attachment to the host cell. Through a series of experiments, the study revealed that VP1 alone can facilitate the viral genome’s access to the nucleus during envelope breakdown. This finding contrasts with other polyomaviruses where additional minor capsid proteins, such as VP2 or VP3, are often crucial for successful infection[4]. By isolating the role of VP1, the team was able to demonstrate that MCPyV’s strategy for nuclear entry is both efficient and uniquely adapted to the cell division process. Insights from previous research on Merkel cell carcinoma also add context to these new findings. Earlier studies detected MCPyV DNA integrated into the genomes of tumor cells and highlighted the virus’s involvement in cancer progression[5]. The ability of MCPyV to enter the nucleus without relying on the NPC could explain part of its oncogenic potential, as it suggests a close relationship between viral replication and the host cell’s own division cycle. Since many cancer cells have aberrant cell cycles or increased rates of division, the timing of nuclear envelope breakdown could provide repeated or enhanced opportunities for the virus to incorporate its genome into host DNA—a critical step in tumor development. This study, therefore, provides a fresh perspective on how MCPyV exploits fundamental cellular processes to establish infection. By relying on cell cycle-dependent nuclear envelope breakdown, MCPyV circumvents the need for the canonical nuclear import pathways that other viruses utilize. This adaptation may reflect an evolutionary divergence that not only facilitates infection but also contributes to the virus’s ability to cause cancer. The use of synchronized cell populations and advanced imaging methods allowed the researchers to dissect this mechanism with precision, offering new insights that could eventually be leveraged for therapeutic interventions. The findings underscore the diversity in strategies employed by polyomaviruses to interact with host cells. In contrast to viruses like SV40, which engage directly with components of the NPC for nuclear entry[3], MCPyV demonstrates that targeting cellular processes during mitosis can be equally effective. This mechanism also reflects the intricate interplay between virus and host, linking MCPyV’s life cycle to the natural rhythms of cell division and providing a potential explanation for its association with rapidly dividing tumor cells. By expanding on earlier research and exploring a novel pathway for nuclear entry, this study not only deepens our understanding of MCPyV biology but also opens new avenues for research into virus-induced cancer mechanisms.

MedicineBiochem

References

Main Study

1) Temporal gating of nuclear import: How Merkel cell polyomavirus exploits the cell cycle for nuclear entry

Published 30th May, 2025

https://doi.org/10.1371/journal.ppat.1013217

Related Studies

2) Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential.

https://doi.org/10.1016/j.virol.2012.09.029

3) Components of the LINC and NPC complexes coordinately target and translocate a virus into the nucleus to promote infection.

https://doi.org/10.1371/journal.ppat.1010824

4) The Merkel cell polyomavirus minor capsid protein.

https://doi.org/10.1371/journal.ppat.1003558

5) Clonal integration of a polyomavirus in human Merkel cell carcinoma.

https://doi.org/10.1126/science.1152586


Related Articles

An unhandled error has occurred. Reload 🗙